翻译进行中 — 您的语言版本正在准备中，目前内容以英语显示。

返回讨论

登录以保存并获取更新。

How AI helps scientists design the next generation of medicines

Healthcare

全球

开始于 July 26, 2026

Designing and developing a new medicine is an expensive, failure-prone scientific challenge. A new drug can take many years to develop, at the cost of a significant investment. And even then, most possible candidates never reach the patient. For biologic medicines, therapies made from engineered proteins rather than synthetic chemistry (which are often used to…

来源文章

How AI helps scientists design the next generation of medicines

MIT Technology Review (United States) | Jul 23, 2026

添加陈述分析 0/5

排序方式：

Need to find a specific claim? Search all statements.

🗳️ Join the conversation

10 条陈述待投票 • Your perspective shapes the analysis

📊 Progress to Consensus Analysis Need: 7+ participants, 20+ votes, 3+ votes per statement

Participants 0/7

Statements (10+ recommended) 10/10

Total Votes 0/20

💡 Progress updates live here. Final readiness is confirmed when all three requirements are met.

Your votes count

No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.

CLAIM 发布者 admin • Jul 26, 2026

AI trained on biased datasets will systematically under-serve medicines for diseases prevalent in low-income countries.

翻译待处理

💬 查看讨论

Be first to respond

Vote to see results

CLAIM 发布者 admin • Jul 26, 2026

Governments should fund open-source AI drug-design platforms to prevent a monopoly by a few wealthy corporations.

翻译待处理

💬 查看讨论

Be first to respond

Vote to see results

CLAIM 发布者 admin • Jul 26, 2026

AI's ability to model rare disease genetics will shift investment toward orphan drugs that were previously unprofitable.

翻译待处理

💬 查看讨论

Be first to respond

Vote to see results

CLAIM 发布者 admin • Jul 26, 2026

AI will enable precision medicine by matching drug candidates to genetic subtypes, making mass-market blockbuster drugs obsolete.

翻译待处理

💬 查看讨论

Be first to respond

Vote to see results

CLAIM 发布者 admin • Jul 26, 2026

Investment in AI for medicine design should be accompanied by strict regulatory oversight to ensure safety.

翻译待处理

💬 查看讨论

Be first to respond

Vote to see results

CLAIM 发布者 admin • Jul 26, 2026

AI's strength in predicting molecular properties makes it most valuable for early-stage research, not as a replacement for clinical judgment.

翻译待处理

💬 查看讨论

Be first to respond

Vote to see results

CLAIM 发布者 admin • Jul 26, 2026

AI-designed drugs are unproven in real patients and regulators must demand identical safety data as traditionally developed medicines.

翻译待处理

💬 查看讨论

Be first to respond

Vote to see results

CLAIM 发布者 admin • Jul 26, 2026

The complexity of biological systems means that AI cannot fully replace human researchers in drug design.

翻译待处理

💬 查看讨论

Be first to respond

Vote to see results

CLAIM 发布者 admin • Jul 26, 2026

Patent law must evolve to credit both human researchers and AI systems fairly, or incentives for human innovation will collapse.

翻译待处理

💬 查看讨论

Be first to respond

Vote to see results

CLAIM 发布者 admin • Jul 26, 2026

Whether or not AI accelerates discovery, drug pricing must remain decoupled from development speed to ensure affordability.

翻译待处理

💬 查看讨论

Be first to respond

Vote to see results

💡 How This Works

• Add Statements: Post claims or questions (10-500 characters)
• Vote: Agree, Disagree, or Unsure on each statement
• Respond: Add detailed pro/con responses with evidence
• Consensus: After enough participation, analysis reveals opinion groups and areas of agreement

Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.